Hemostatic equipment for emergency treatment of esophageal venous hemorrhage
By designing a movable and partially expandable inner and outer tube structure, combined with the balloon structure, rapid and accurate hemostasis of esophageal venous bleeding is achieved, solving the problems of low position adjustment efficiency and drug arrival in the prior art, and improving the hemostasis effect.
Patent Information
- Application Number
- CN202420215945.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Utility models(China)
- Current Assignee / Owner
- Filing Date
- 2024-01-29
- Publication Date
- 2024-11-08
- Estimated Expiration
- 2034-01-29
AI Technical Summary
Existing esophageal venous bleeding hemostasis equipment cannot be quickly adjusted according to the location of the bleeding point, resulting in low operation efficiency and pain in the patient. In addition, the traditional three-chamber two-cystic tubes are easily damaged to the inner wall of the esophageal wall when the airbag position is adjusted, and the hemostatic drugs cannot effectively reach the bleeding. point.
A hemostatic device including an outer tube and an inner tube is designed. The inner tube can move and expand locally in the interlayer space, release hemostatic drugs through the micropores of the outer tube, achieving the dual effects of drug hemostatic and compression hemostatic, and through the balloon The structure performs adjustable position in the esophagus to stop bleeding.
It improves the accuracy and efficiency of hemostasis, reduces damage to the inner wall of the esophagus, ensures that the hemostasis drugs effectively reach the bleeding point, and reduces the work burden of doctors and the pain of patients.
Smart Images

Figure CN221963659U_ABST
Abstract
Description
Technical Field
[0001] The utility model relates to the technical field of medical devices, in particular to a hemostatic device for emergency treatment of esophageal venous bleeding. Background Art
[0002] In the clinical treatment of gastroenterology, some patients with digestive system diseases may develop esophageal varices as the course of the disease prolongs. If this situation is not paid attention to, it will cause esophageal venous bleeding and endanger life. Some esophageal bleeding occurs very suddenly, and if the bleeding is not stopped in time, it will also cause heavy bleeding. For esophageal bleeding, blood transfusion and taking hemostatic drugs can be used for treatment. The disadvantage is that the effect is slow during treatment and the purpose of rapid hemostasis cannot be achieved. In addition, there is also a method of using a three-chamber two-balloon tube for compression hemostasis. Its working principle is: the tube body is extended into the patient's esophagus, and the airbag is inflated with an external inflation device to press the bleeding point to achieve compression hemostasis. The disadvantage of this method is that: since the airbag is fixedly set on the tube body, after the tube body is inserted into the esophagus, the position of the airbag is relatively fixed, and it cannot be adaptively adjusted according to the position of the bleeding point, so that the airbag cannot be moved to the bleeding point in time for rapid hemostasis. In order to move the airbag, the tube body needs to be moved up and down, which is time-consuming and labor-intensive, reduces the doctor's work efficiency, and also brings unnecessary pain to the patient.
[0003] In the prior art, a patent document with announcement number CN201617890U proposes a sliding esophageal bleeding hemostat, which is composed of a tube body, a hemostatic airbag and an inflation tube. A lumen is provided in the middle of the tube body, the inflation tube is connected to the hemostatic airbag, a socket and a valve are provided at the rear end of the inflation tube, two slideways are symmetrically provided on the outer wall of the tube body, an annular sleeve is provided on the tube body, and two sliders on the inner side of the annular sleeve are respectively provided in the corresponding two slideways, one of the sliders is fixed with an upper slider operating handle at the upper end, and the hemostatic airbag is fixed on the outer wall of the annular sleeve. Although the device can be adjusted in time according to the specific situation of the bleeding point of the patient's esophagus, shortening the operation time, the device can only be used for mechanical compression hemostasis, and for some milder bleeding symptoms, the hemostasis is not thorough.
[0004] In addition, on the one hand, there are differences in understanding among technical personnel in this field; on the other hand, the applicant studied a large number of documents and patents when making the present utility model, but due to space limitations, not all details and contents are listed in detail. However, this does not mean that the present utility model does not have the characteristics of these prior arts. On the contrary, the present utility model already has all the characteristics of the prior art, and the applicant reserves the right to add relevant prior art to the background technology. Utility Model Content
[0005] In order to adapt to the hemostasis requirements of different bleeding locations, the prior art has already appeared a technical solution that can adjust the position of the hemostatic airbag. For example, the patent document with the announcement number CN204170277U discloses a gastric tube with local hemostasis, which is mainly composed of a tube body and a sleeve sleeved on the tube body. The tube body and the sleeve both have a distal end and a proximal end. A first airbag is arranged at a position close to the distal end of the sleeve, and a first inflation nozzle is arranged at the proximal end of the sleeve. A first inflation channel connecting the first inflation nozzle and the first airbag is arranged inside the sleeve, and the sleeve and the tube body are slidably matched. The first airbag used to fix the position of the gastric tube on the gastric tube of this technical solution can arbitrarily adjust its position at the distal end of the tube body by pulling the sleeve, and then the position of the first airbag can be freely adjusted according to the position of the patient's gastric bleeding, so that the local hemostasis effect of the airbag can be fully exerted. However, although this technical solution also involves a double-layer tube structure that can perform relative displacement, the specific setting method of its tube body is completely opposite to the technical solution of the utility model. On the one hand, the airbag structure capable of moving position in this technical solution is located in the outer layer, and the inflation and compression hemostasis process of the airbag is realized by the outer tube structure. In this process, the tube body needs to be moved up and down to adjust the specific action position of the airbag. At this time, the movement of the outer tube body will cause the tube body structure and the balloon structure thereon to have multiple relative frictions with the inner wall of the patient's esophagus, thereby causing the defect of secondary damage to the esophageal bleeding point; on the other hand, the airbag structure in this technical solution will contact the inner wall of the esophagus when it is extended into the patient's esophagus, and thus it is impossible to set hemostatic drugs thereon. Once the device is extended into the patient's esophagus, the hemostatic drugs on the airbag will directly contact the inner wall of the esophagus, resulting in unexpected shedding of the hemostatic drugs and failure to reach the expected position for hemostasis.
[0006] In view of the deficiencies of the prior art, the present application proposes an esophageal hemostasis device, in particular, a hemostasis device with an adjustable hemostasis site for emergency treatment of esophageal venous bleeding, aiming to solve one or more technical problems in the prior art.
[0007] In the prior art, a three-chamber two-balloon tube is usually used to treat esophageal bleeding. The working principle of this method is to insert the tube body into the patient's esophagus, and then use an external inflation device to inflate the balloon to compress the bleeding point to achieve hemostasis. However, since the balloon is fixed on the tube body, the position of the balloon is relatively fixed after the tube body is inserted into the esophagus, and it cannot be adaptively adjusted according to the position of the bleeding point. In order to move the balloon to the bleeding point, the tube body needs to be moved up and down, which is time-consuming and laborious, reducing the doctor's work efficiency, and also causing unnecessary pain to the patient. Therefore, a new hemostatic device is needed that can quickly and accurately compress and stop bleeding, while reducing the doctor's workload and improving the patient's experience.
[0008] Therefore, in response to the above-mentioned technical problems, the utility model proposes a hemostatic device for emergency treatment of esophageal venous bleeding, which can be inserted into the patient's esophagus and stop bleeding at the bleeding site, comprising an outer tube and an inner tube, the inner diameter of the outer tube is larger than that of the inner tube to leave an interlayer space between the inner tube and the outer tube, the inner tube can move in the interlayer space, a plurality of micropores are opened on the tube wall of the outer tube, and the tube wall of the inner tube is provided with a hemostatic drug, wherein, when the inner tube is connected to an external inflation device, the inner tube moved to a predetermined position can locally expand in the interlayer space, so that the corresponding position of the outer tube also locally expands and adheres to the esophageal bleeding site to achieve compression hemostasis, and the expanded hemostatic drug is attached to the tube wall of the outer tube and released to the esophageal bleeding site through the micropores to achieve drug hemostasis.
[0009] There are already technical solutions in the prior art for administering drugs by setting a number of hole structures. For example, the patent document with the announcement number CN208726399U discloses a device for gastric washing and drug administration, including an insertion tube with an air bag at one end, a drug administration tube sleeved inside the other end of the insertion tube, a number of through holes on the insertion tube, and a liquid flow control device between the insertion tube and the drug administration tube. The technical solution extends the insertion tube into the stomach or the part to be used for the drug, and can adjust the drug administration tube and the insertion tube, control the positional relationship between the sealing block and the shrinkage, select the connection and sealing between the insertion tube and the drug administration tube, and inject drugs or water through the drug administration tube when connected to treat or clean the stomach. However, the through hole structure in the technical solution is arranged on the insertion tube connected to the liquid drug administration tube, and the tubular structure cannot be deformed according to the collision of the air bag, and once the insertion tube is filled with liquid medicine, all the through holes will serve as the entry channel of the liquid medicine, and the directional liquid medicine supply cannot be achieved. Compared with the above-mentioned prior art, the inner tube in the utility model can move in the interlayer space formed between the inner tube and the outer tube, so that the inner tube structure carrying the airbag can move to the predetermined hemostasis position, and in the process of local expansion of the inner tube in the interlayer space, the hemostatic drug on the inner tube can be released to the bleeding site of the esophagus through the micropores on the wall of the outer tube, so as to achieve drug hemostasis while compressing hemostasis. Based on the above-mentioned distinguishing technical features, the technical problems to be solved by the utility model may include: how to reduce the damage to the inner wall of the esophagus during the adjustment of the airbag position and improve the effectiveness of hemostasis. Specifically, the hemostatic device of the utility model is configured with an inner tube that is arranged in the outer tube and can move freely in the interlayer space, so that it can be adaptively adjusted according to the specific position of the bleeding point in the esophagus through the operation of lifting and lowering. In the process of adjusting the inner tube, the relative position of the outer tube is fixed, thereby avoiding the situation that the traditional three-chamber two-balloon tube needs to move the tube body up and down to adjust the position of the airbag and scratch the patient's esophagus, reducing the patient's pain and improving the accuracy and efficiency of hemostasis. At the same time, since the expandable part of the inner tube is provided with hemostatic drugs, the hemostatic device of the utility model has the dual functions of drug hemostasis and compression hemostasis, thereby improving the effect of hemostatic treatment.
[0010] According to a preferred embodiment, a balloon is provided at the proximal end of the inner tube, and the balloon can expand when the inner tube body is inflated, thereby squeezing the tube wall of the outer tube. Compared with the above-mentioned prior art, the balloon structure on the inner tube in the utility model can squeeze the tube wall of the outer tube in its expanded state. Based on the above-mentioned distinguishing technical features, the technical problems to be solved by the utility model may include: how to achieve position-adjustable compression hemostasis through the built-in balloon structure. Specifically, since the balloon has a larger elastic coefficient than the tube body of the inner tube, it makes it easier for the balloon to expand when the inner tube is filled with gas, thereby squeezing the tube wall of the outer tube to achieve the effect of compression hemostasis. Furthermore, since the position of the inner tube provided with the balloon can be moved inside the outer tube, and the position of the outer tube does not move relative to the esophageal wall after being inserted into the esophagus, compression hemostasis can be achieved for bleeding points at different positions by moving the inner tube.
[0011] According to a preferred embodiment, a mounting seat is detachably provided at the proximal end of the inner tube, and the mounting seat includes a top ring and a bottom ring, and a developing member for developing is sleeved between the top ring and the bottom ring. Compared with the above-mentioned prior art, a mounting seat adjacent to the balloon is provided on the inner tube of the utility model. Based on the above-mentioned distinguishing technical features, the technical problems to be solved by the utility model may include: how to achieve the positioning of the balloon. Specifically, by providing a developing member that can be displayed on an X-ray machine or other equipment at the proximal end of the inner tube in order to confirm the relative position of the balloon, this provides an adjustment basis for medical staff to lift and lower the inner tube.
[0012] According to a preferred embodiment, the proximal end of the inner tube is provided with a seal for sealing the tube opening, and the seal allows the gas entering the inner tube to gather at the balloon to expand the balloon. The distal end of the inner tube is provided with an inflation component, and the inflation component can establish an inflation channel between the lumen of the inner tube and the external inflation device. The seal can seal the proximal tube opening of the inner tube, so that the inner tube does not have other vents except the tube opening at its distal end. In addition, by arranging the inflation component at the tube opening at the distal end of the inner tube, most of the gas filled into the inner tube by the external inflation device with the aid of the inflation component is used for the expansion of the balloon, so that the expansion degree of the balloon can be regulated by controlling the air intake of the external inflation device, so that the size of the inflated balloon can match the inner diameter of the patient's esophagus.
[0013] According to a preferred embodiment, the hemostatic drug disposed on the wall of the inner tube is located above the top ring, and the hemostatic drug is arranged around the balloon in the form of a hemostatic dressing in a gel state, so that it can deform as the balloon expands, and then contact the wall of the outer tube. Compared with the above-mentioned prior art, the utility model is provided with a hemostatic drug on the outer surface of the balloon structure. Based on the above-mentioned distinguishing technical features, the technical problems to be solved by the utility model may include: how to implement the application of the hemostatic drug according to the expansion process of the balloon. Specifically, the hemostatic dressing is arranged on the outside of the balloon in a surrounding form, so that its expansion direction and expansion degree can be consistent with those of the balloon, thereby improving the synchronization of the deformation of the two and facilitating medical staff to perform drug hemostasis operations.
[0014] According to a preferred embodiment, a binding piece is provided at the distal end of the outer tube, and the binding piece is used to fix the inner tube so that the inner tube can be fixed at a predetermined position corresponding to the esophageal bleeding site. After the inner tube moves to the predetermined position, the binding piece is used to fix the inner tube so that it can remain in the correct hemostatic position for a long time until blood coagulation is completed.
[0015] According to a preferred embodiment, the inflation component includes a sealing baffle and a sealing interface. The sealing baffle is arranged in the sealing interface. The sealing baffle can remain closed when the sealing interface is not connected to an external inflation device, and can elastically deform when the sealing interface is connected to an external inflation device to connect the inflation channel between the external inflation device and the inner tube.
[0016] According to a preferred embodiment, when the balloon is not inflated, the cross-sectional area of the balloon is smaller than the area of the top ring of the mounting seat, so that the hemostatic dressing can be placed on the top ring of the mounting seat to avoid slipping off the inner tube. The surface of the balloon is provided with a plurality of anti-skid ribs that enhance the friction between it and the hemostatic dressing. Compared with the above-mentioned prior art, the cross-sectional area of the balloon structure of the utility model in the initial state is smaller than the area of the top ring of the mounting seat, and a rib structure that can increase its surface area is provided on the surface of the balloon. Based on the above-mentioned distinguishing technical features, the technical problems to be solved by the utility model may include: how to improve the adhesion between the hemostatic dressing and the balloon structure to prevent the hemostatic dressing from accidentally slipping off the balloon. Specifically, the supporting force provided by the top ring of the mounting seat and the friction provided by the anti-skid ribs on the surface of the balloon can prevent the hemostatic dressing from falling off the inner tube regardless of whether the balloon is inflated. BRIEF DESCRIPTION OF THE DRAWINGS
[0017] Figure 1 This is a schematic diagram of the overall structure of the hemostatic device of the utility model before the balloon is expanded;
[0018] Figure 2 is a perspective view of the balloon of the hemostatic device of the utility model before expansion;
[0019] Figure 3 This is a schematic diagram of the overall structure of the hemostatic device of the utility model after the balloon is expanded;
[0020] Figure 4 It is a perspective view of the balloon of the hemostatic device of the utility model after expansion.
[0021] Reference numerals list
[0022] 100: inner tube; 110: balloon; 120: mounting seat; 121: top ring; 122: bottom ring; 130: developing part; 140: hemostatic dressing; 150: inflation component; 151: sealing baffle; 152: sealing interface; 200: outer tube; 210: micropore; 220: binding part. DETAILED DESCRIPTION
[0023] The utility model is described in detail below in conjunction with the accompanying drawings.
[0024] Definition of orientation: the end close to the patient's esophageal bleeding site is the proximal end, and the end away from the patient's esophageal bleeding site is the distal end.
[0025] Example 1
[0026] The utility model relates to a hemostatic device for emergency treatment of esophageal venous bleeding, which can be partially placed in the esophagus of a patient to stop bleeding at the bleeding site. Figure 1 , Figure 2As shown, it includes an outer tube 200 with a relatively larger inner diameter and an inner tube 100 with a relatively smaller inner diameter. The difference in inner diameter enables the inner tube 100 to be built into the outer tube 200 and to move freely in the outer tube 200. A certain interlayer space is reserved outside the tube wall of the inner tube 100 and inside the tube wall of the outer tube 200. A hemostatic drug is arranged in the interlayer space. The thickness of the hemostatic drug is smaller than the interlayer space, so that the movement of the inner tube 100 will not be interfered by the hemostatic drug. Preferably, the hemostatic drug is attached to the tube wall of the inner tube 100. A plurality of micropores 210 are provided on the tube wall of the outer tube 200, which are used to connect the interlayer space and the external space outside the tube wall of the outer tube 200. Preferably, the local areas of the inner tube 100 and the outer tube 200 are elastic, which means that both the inner tube 100 and the outer tube 200 can undergo a certain degree of elastic deformation under the action of external force to change the size of the space they occupy in the patient's esophagus. Specifically, the inner tube 100 can be connected to an external inflation device. When the inner tube 100 moves to a predetermined position, it partially expands in the interlayer space under the action of the gas filled by the external inflation device. The continuously enlarging inner tube 100 gradually occupies the interlayer space completely, and then the portion of the outer tube 200 corresponding to the expanded position of the inner tube 100 can also expand. The predetermined position of the inner tube 100 refers to the position of the inner tube 100 when the expanded area of the inner tube 100 corresponds to the bleeding site of the patient's esophagus when the medical staff lifts and lowers the inner tube 100 to adjust the position of the inner tube 100. The external inflation device can be, for example, an air pump, a syringe, or other equipment. After such an expansion deformation occurs, the outer tube 200 can be attached to the bleeding site of the patient's esophagus to achieve compression-based hemostasis. Moreover, the expansion of the inner tube 100 can also drive the expansion of the hemostatic drug located in the expansion area, thereby sandwiching the hemostatic drug between the tube wall of the inner tube 100 and the tube wall of the outer tube 200, so that the hemostatic drug can pass through the micropores 210 opened on the tube wall of the outer tube 200 and release drug molecules toward the esophageal bleeding site of the patient, so as to achieve drug-based hemostasis.
[0027] Preferably, if Figure 1 , Figure 2As shown, the expansion function of the inner tube 100 is realized by the balloon 110. The balloon 110 is arranged at the proximal end of the inner tube 100, and can expand when the tube body of the inner tube 100 is inflated, thereby squeezing the tube wall of the outer tube 200. Preferably, the balloon 110 can be made of a two-component injection molding process with the tube body of the inner tube 100, and the material used is a material with stronger elastic deformation ability than the tube body material of the inner tube 100. For example, the tube body is made of a high-strength, durable medical-grade plastic, which enables medical staff to more conveniently control the extension direction of the inner tube 100, and has higher stability and safety during use; the balloon 110 is made of a soft and elastic material, which can maintain a good shape and function under pressure. Preferably, the balloon 110 can also be separately sleeved on the outside of the wall of the inner tube 100. By opening a plurality of ventilation holes connected to the balloon 110 on the wall of the inner tube 100, during the inflation process of the inner tube 100, gas can enter the balloon 110 through the ventilation holes, thereby causing the balloon 110 to expand, thereby playing the role of compressing hemostasis and applying hemostatic drugs.
[0028] Preferably, the proximal end of the inner tube 100 is detachably provided with a mounting seat 120, and the mounting seat 120 includes a top ring 121 and a bottom ring 122, and a developing member 130 for developing is sleeved between the top ring 121 and the bottom ring 122. Medical staff often use gastroscope or esophagoscopy to check the specific bleeding point of the patient's esophagus, and can also find the bleeding point by X-ray barium contrast examination or CT examination. By setting the developing member 130 that can be displayed on an X-ray machine and other equipment at the proximal end of the inner tube 100, the medical staff can quickly and accurately determine the relative position of the balloon 110 when using the hemostasis device of the utility model to stop bleeding for the patient, thereby providing a basis for adjusting the position of the inner tube 100. Preferably, the developing member 130 can be an X-ray developing marker ring, which can be imaged and developed under X-rays by adding a composite polymer of Wu, Ba, Bi or Pt, and is soft in texture and can be easily combined with the mounting seat 120. Preferably, the bottom ring 122 is detachably disposed on the mounting seat 120 , and the removal and installation of the bottom ring 122 can further facilitate the arrangement and fixation of the developing member 130 .
[0029] Preferably, a seal capable of blocking the tube opening is specially provided at the proximal end of the inner tube 100. The seal ensures that the gas entering the inner tube 100 is mainly concentrated at the balloon 110, so that the balloon 110 can be expanded. In order to achieve effective gas filling and control, the distal end of the inner tube 100 is provided with an inflation assembly 150, which establishes an inflation channel between the inner tube 100 and the external inflation device. It is worth mentioning that the seal not only blocks the proximal tube opening of the inner tube 100, but also ensures that the inner tube 100 has no vents at other positions except the distal tube opening. This design further enhances the concentration of gas and ensures the accurate expansion of the balloon 110. In addition, by providing the inflation assembly 150 at the tube opening at the distal end of the inner tube 100, most of the gas filled by the external inflation device will be directly used for the expansion of the balloon 110. Such a design makes it possible to adjust the expansion degree of the balloon 110 by simply controlling the air intake of the external inflation device. Finally, the size of the inflated balloon 110 matches the inner diameter of the patient's esophagus.
[0030] Preferably, if Figure 1 , Figure 2 As shown, a hemostatic dressing 140 (i.e., a hemostatic drug) is placed on the top ring 121, and the hemostatic dressing 140 surrounds the outside of the balloon 110. As the balloon 110 expands or contracts, it will also deform accordingly. Such a design ensures that the hemostatic dressing 140 can perfectly fit the tube wall of the outer tube 200, preparing for the subsequent hemostatic operation. In order to achieve the best expansion effect and ensure the synchronization of the expansion direction and degree of the hemostatic dressing 140 and the balloon 110, the hemostatic dressing 140 is arranged on the outside of the balloon 110 in a surrounding form, so that it can expand with the expansion of the balloon 110 and maintain a consistent expansion direction and degree. This design significantly improves the synchronization of the deformation of the hemostatic dressing 140 and the balloon 110, thereby optimizing the hemostatic effect. Through this design, when performing hemostatic operations, medical staff can adjust the air intake of the external inflation device as needed, so as to control the expansion degree of the hemostatic dressing 140 and the balloon 110 more conveniently and efficiently. This precise control capability not only improves the hemostatic effect, but also significantly improves the work efficiency of medical staff. Preferably, the hemostatic dressing 140 uses a hemostatic gel, which is more controllable than liquid hemostatic drugs. Medical staff can accurately place it at the position where hemostasis is required, and its deformation performance enables it to fit closely with the wall of the outer tube 200, thereby improving the hemostatic effect. In addition, the hemostatic gel has higher stability. When it contacts blood or other body fluids, it can maintain its shape and structure, which helps to ensure the durability of the hemostatic effect. It does not need to be applied or sprayed on the expanded part of the inner tube 100 like liquid hemostatic drugs, which can simplify the operation steps and improve the convenience of use.
[0031] Preferably, if Figure 1 , Figure 2As shown, when the balloon 110 is not inflated, its cross-sectional area is carefully designed to ensure that it is smaller than the area of the top ring 121 of the mounting seat 120. This difference in size ensures that the hemostatic dressing 140 can be firmly placed on the top ring 121 of the mounting seat 120, and will not easily slip off the inner tube 100. In order to further enhance the adhesion between the hemostatic dressing 140 and the balloon 110, a number of anti-skid ribs are provided on the surface of the balloon 110. These ribs are made of wear-resistant and anti-skid materials and can be tightly combined with the surface of the balloon 110. They not only increase the friction coefficient of the surface of the balloon 110, but also effectively prevent the hemostatic dressing 140 from slipping on the balloon 110. Figure 3 , Figure 4 As shown, the hemostatic dressing 140 slips off the inner tube 100 after expansion. By using the top ring 121 of the mounting seat 120 and the anti-skid ribs on the surface of the balloon 110, whether the balloon 110 is expanded or not, the hemostatic dressing 140 can be placed at the corresponding position of the inner tube 100 in a relatively stable posture by relying on the support force provided by the top ring 121 or the friction force provided by the anti-skid ribs on the surface of the balloon 110, thereby avoiding the possibility of the hemostatic dressing 140 slipping off the inner tube 100. This design ensures that the hemostatic dressing 140 can remain stable under various operating conditions, providing greater operating convenience and reliability for medical staff.
[0032] Preferably, if Figure 1 to Figure 4 As shown, the outer tube 200 is provided with a binding member 220 at the distal end thereof, and the binding member 220 is used to fix the inner tube 100 so that the inner tube 100 can be fixed at a predetermined position corresponding to the esophageal bleeding site. After the inner tube 100 moves to the predetermined position, the binding member 220 is used to fix the inner tube 100 so that it can be kept at the correct hemostatic position for a long time until the blood coagulation is completed. Preferably, the binding member 220 can be in the form of an elastic bandage or a Velcro.
[0033] Preferably, if Figure 1 to Figure 4As shown, the inflatable component 150 includes a sealing baffle 151 and a sealing interface 152. The sealing baffle 151 is arranged in the sealing interface 152, and is configured so that at least a part of the area is kept in contact with the inner wall of the sealing interface 152, while the remaining area has a certain elasticity and can be elastically deformed under the action of the air pressure difference. The sealing baffle 151 can remain closed when the sealing interface 152 is not connected to the external inflatable device, and can be elastically deformed when the sealing interface 152 is connected to the external inflatable device to connect the inflation channel between the external inflatable device and the inner tube 100. Specifically, when the sealing interface 152 is not connected to the external inflatable device, the sealing baffle 151 remains in a closed state. At this time, the shape of the sealing baffle 151 is fixed, and is not affected by external forces, so no elastic deformation occurs. When the sealing interface 152 is connected to the external inflatable device, the sealing baffle 151 is affected by external forces and begins to be elastically deformed. This deformation process is dynamic. As the air pressure applied by the inflatable device to the sealing baffle 151 increases, the sealing baffle 151 gradually bends inward to form an opening, thereby connecting the inflation channel between the external inflatable device and the inner tube 100. During this deformation process, the sealing baffle 151 changes from a closed state to an open state, allowing gas to flow from the external inflatable device into the inner tube 100. When inflation is completed, the sealing baffle 151 returns to its original shape under the action of elastic force, recloses the sealing interface 152, and cuts off the inflation channel.
[0034] Preferably, the material of the inner tube 100 and the outer tube 200 is polyurethane. Polyurethane has very good biocompatibility and has no adverse effects on the human body. In addition, its price is relatively low, so that the hemostatic device of the utility model can be preferably set as a disposable item, which is used by one person only, so as to ensure hygiene and avoid cross infection. The hemostatic device can be discarded after use without cleaning and disinfection, which simplifies the operation process and reduces the risk of infection caused by improper operation.
[0035] Example 2
[0036] This embodiment is a further improvement on Embodiment 1, and the repeated contents will not be repeated here.
[0037] In order to optimize the number of components of the hemostatic device for emergency treatment of esophageal venous bleeding, the present embodiment simplifies the hemostatic device. Figure 1 , Figure 2For example, in this embodiment, the balloon 110 is not provided on the inner tube 100, and the tube body of the inner tube 100 can be made of a material with similar elastic deformation ability as the balloon 110, so that the inner tube 100 can be expanded as a whole under the inflation of the external inflation device, and it is no longer necessary to adjust its expansion area through lifting and lowering operations. Furthermore, the overall expansion property of the inner tube 100 also makes it unnecessary for medical staff to adjust the position of the inner tube 100 according to the bleeding site in the patient's esophagus, so that the binding member 220 and the developing member 130 are no longer necessary structures and can also be eliminated.
[0038] Preferably, since the inner tube 100 no longer needs to be lifted and lowered, it can be fixedly connected to the bottom surface of the proximal end of the outer tube 200. The mounting seat 120 provided at the proximal end of the inner tube 100 can only retain the top ring 121, which can provide a basis for the placement of the hemostatic dressing 140. As another embodiment, the mounting seat 120 can also be selected to be completely cancelled. Under such a scheme, the hemostatic dressing 140 has a tendency to slide on the wall of the inner tube 100 due to the loss of the support of the top ring 121. To avoid this situation, the hemostatic dressing 140 can completely fill the space between the inner tube 100 and the outer tube 200 by increasing its thickness. With such a design, the hemostatic dressing 140 can be clamped by the tube wall of the inner tube 100 and the tube wall of the outer tube 200 at the same time, so as to use the pre-tightening force provided by the two to ensure that the hemostatic dressing 140 will not undergo unexpected deformation before the inner tube 100 expands.
[0039] It should be noted that the above specific embodiments are exemplary, and those skilled in the art can come up with various solutions inspired by the disclosure of the utility model, and these solutions also belong to the disclosure scope of the utility model and fall within the protection scope of the utility model. Those skilled in the art should understand that the utility model specification and its drawings are illustrative and do not constitute a limitation on the claims. The scope of protection of the utility model is defined by the claims and their equivalents. Throughout the text, the features guided by "preferably" are only an optional method and should not be understood as having to be set, so the applicant reserves the right to abandon or delete the relevant preferred features at any time.
Claims
1. A hemostatic device for emergency treatment of esophageal venous bleeding, which can be inserted into the patient's esophagus and stop bleeding at the bleeding site. It is characterized in that The invention comprises an outer tube (200) and an inner tube (100), wherein the inner diameter of the outer tube (200) is larger than that of the inner tube (100) so as to leave an interlayer space between the inner tube (100) and the outer tube (200), and the inner tube (100) can move in the interlayer space, a plurality of micropores (210) are formed on the tube wall of the outer tube (200), and a hemostatic drug is disposed on the tube wall of the inner tube (100). In which, when the inner tube (100) is connected to an external inflation device, the inner tube (100) moved to a predetermined position can locally expand in the interlayer space, so that the corresponding position of the outer tube (200) also locally expands and adheres to the bleeding site of the esophagus to achieve compression hemostasis, and the expanded hemostatic drug is attached to the tube wall of the outer tube (200) and released to the bleeding site of the esophagus through the micropores (210) to achieve drug hemostasis.
2. The hemostasis device according to claim 1, It is characterized in that A balloon (110) is disposed at the proximal end of the inner tube (100). The balloon (110) can expand when the inner tube (100) is inflated, thereby squeezing the wall of the outer tube (200).
3. The hemostasis device according to claim 2, It is characterized in that A mounting seat (120) is detachably provided at the proximal end of the inner tube (100), wherein the mounting seat (120) comprises a top ring (121) and a bottom ring (122), and a developing member (130) for developing is sleeved between the top ring (121) and the bottom ring (122).
4. The hemostasis device according to claim 2, It is characterized in that The proximal end of the inner tube (100) is provided with a sealing member for sealing the tube opening, and the sealing member allows the gas entering the inner tube (100) to gather at the balloon (110) so as to expand the balloon (110).
5. The hemostasis device according to claim 1, It is characterized in that The distal end of the inner tube (100) is provided with an inflation component (150), and the inflation component (150) can establish an inflation channel between the lumen of the inner tube (100) and an external inflation device.
6. The hemostasis device according to claim 3, It is characterized in that The hemostatic drug disposed on the wall of the inner tube (100) is located above the top ring (121), and the hemostatic drug is disposed around the balloon (110) in the form of a gel-state hemostatic dressing (140), so that it can deform as the balloon (110) expands, and then contact the wall of the outer tube (200).
7. The hemostasis device according to claim 1, It is characterized in that A binding member (220) is provided at the distal end of the outer tube (200), and the binding member (220) is used to fix the inner tube (100) so that the inner tube (100) can be fixed at a predetermined position corresponding to the esophageal bleeding site.
8. The hemostasis device according to claim 5, It is characterized in that The inflation component (150) comprises a sealing baffle (151) and a sealing interface (152); the sealing baffle (151) is arranged in the sealing interface (152); the sealing baffle (151) can remain closed when the sealing interface (152) is not connected to an external inflation device, and can elastically deform when the sealing interface (152) is connected to an external inflation device to connect the inflation channel between the external inflation device and the inner tube (100).
9. The hemostasis device according to claim 6, It is characterized in that When the balloon (110) is not inflated, the cross-sectional area of the balloon (110) is smaller than the area of the top ring (121) of the mounting seat (120), so that the hemostatic dressing (140) can be placed on the top ring (121) of the mounting seat (120) to avoid slipping off the inner tube (100).
10. The hemostasis device according to claim 6, It is characterized in that The surface of the balloon (110) is provided with a plurality of anti-slip ribs for enhancing the friction between the balloon (110) and the hemostatic dressing (140).
